Phase ib/2a study of PLX51107, a small molecule BET inhibitor, in subjects with advanced hematological malignancies and solid tumors.

标题
Phase ib/2a study of PLX51107, a small molecule BET inhibitor, in subjects with advanced hematological malignancies and solid tumors.
作者
关键词
-
出版物
JOURNAL OF CLINICAL ONCOLOGY
Volume 36, Issue 15_suppl, Pages 2550-2550
出版商
American Society of Clinical Oncology (ASCO)
发表日期
2018-09-05
DOI
10.1200/jco.2018.36.15_suppl.2550

向作者/读者发起求助以获取更多资源

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started